Azenta (NASDAQ:AZTA) Releases Q3 2022 Earnings Guidance

Azenta (NASDAQ:AZTA – Get Rating) updated its third quarter 2022 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $0.09-$0.17 for the period, compared to the consensus estimate of $0.18. The company issued revenue guidance of $140.00 million-$150.00 million, compared to the consensus revenue estimate of $150.38 million.

Shares of NASDAQ AZTA opened at $77.77 on Monday. Azenta has a 1 year low of $61.35 and a 1 year high of $124.79. The company’s 50-day simple moving average is $77.52. The stock has a market cap of $5.83 billion, a PE ratio of 2.63 and a beta of 1.65.

Azenta (NASDAQ:AZTA – Get Rating) last released its earnings results on Monday, May 9th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.01. The firm had revenue of $145.60 million during the quarter, compared to analyst estimates of $142.10 million. Azenta had a net margin of 301.05% and a return on equity of 4.28%. The business’s revenue was up 12.3% on a year-over-year basis. During the same period last year, the business earned $0.61 earnings per share. Analysts expect that Azenta will post 0.54 EPS for the current year.

AZTA has been the subject of several analyst reports. Needham & Company LLC reduced their price target on Azenta from $115.00 to $94.00 in a report on Tuesday, May 10th. B. Riley reduced their price objective on shares of Azenta from $106.00 to $94.00 in a research note on Tuesday, May 17th. Zacks Investment Research raised shares of Azenta from a sell rating to a hold rating in a report on Monday, May 23rd. Finally, Evercore ISI began coverage on shares of Azenta in a report on Monday, March 21st. They set an outperform rating and a $100.00 price target on the stock.

Azenta Company Profile (Get Rating)

Azenta, Inc provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in two segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated ultra-cold storage systems and consumables, including racks, tubes, caps, plates, and foils; instruments, such as labeling, bar coding, capping, de-capping, auditing, sealing, peeling, piercing tubes, and plates.

Recommended Stories